Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:59:18 EDT Thu 14 Aug 2025
Enter Symbol
or Name
USA
CA



Q:CPIX - CUMBERLAND PHARMACEUTICALS INC - https://www.cumberlandpharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CPIX - Q1.02.82·4.390.92.93+0.020.746.71152812.96  3.00  2.857.25  1.04Aug 13Aug 0515 min RT 2¢

Recent Trades - Last 10 of 281
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-08-05 16:05U:CPIXNews ReleaseCumberland Pharmaceuticals Reports 23% Revenue Growth Year-to-Date
2025-08-04 09:05U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS RECEIVES VIZIENT CONTRACT FOR NEW VIBATIV(TM) 4-VIAL STARTER PAK
2025-07-29 16:05U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q2 2025 FINANCIAL RESULTS & COMPANY UPDATE
2025-06-23 09:05U:CPIXNews ReleaseCumberland Pharmaceuticals Shares Phase 2 FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference
2025-05-27 16:05U:CPIXNews ReleaseNEW STUDY FINDS CALDOLOR(TM) SAFE AND EFFECTIVE FOR OPIOID-SPARING PAIN MANAGEMENT IN OLDER ADULTS
2025-05-13 16:05U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS PARTNERS WITH QUREIGHT TO ADVANCE INNOVATIVE IDIOPATHIC PULMONARY FIBROSIS TREATMENT RESEARCH
2025-05-06 16:05U:CPIXNews ReleaseCumberland Pharmaceuticals Reports 38% Revenue Growth in Q1 2025
2025-04-29 16:05U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2025 FINANCIAL RESULTS & COMPANY UPDATE
2025-03-19 16:05U:CPIXNews ReleaseFIGHT DMD Trial Results Selected for Late-Breaking Presentation at MDA Clinical & Scientific Conference
2025-03-04 16:05U:CPIXNews ReleaseCumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth
2025-02-25 16:05U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2024 FINANCIAL RESULTS
2025-02-18 07:30U:CPIXNews ReleaseVIBATIV(TM) RECEIVES MARKETING APPROVAL IN CHINA
2025-02-04 07:30U:CPIXNews ReleaseCumberland Pharmaceuticals Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart Disease
2024-12-09 16:05U:CPIXNews ReleaseFDA APPROVES ACETADOTE(TM) sNDA
2024-11-07 16:05U:CPIXNews ReleaseCumberland Pharmaceuticals Reports Third Quarter 2024 Financial Results and Company Update
2024-11-06 17:21U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG AND RARE PEDIATRIC DISEASE DESIGNATIONS FOR NEW TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
2024-11-05 16:05U:CPIXNews ReleaseNew Study Compares Caldolor(TM) (ibuprofen injection) to ketorolac
2024-10-31 16:05U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS